" Psyched Wellness (CSE:PSYC) announces successful pilot run & final flavour profile for Calm
Psyched Wellness (PSYC) has announced positive feedback from a pilot run of 300 bottles of Calm.
" Origin Therapeutics’ (CSE:ORIG) Xpira Pharmaceuticals receive FDA approval for psilocybin
Origin Therapeutics’ (ORIG) company, Xpira Pharmaceuticals, receives FDA approval for psilocybin for a trial IND application.
" Optimi Health (CSE:OPTI), ATMA Journey Centres to proceed with Phase I natural psilocybin and MDMA clinical trial application to Health Canada
Optimi Health (OPTI) has confirmed its intent to proceed with a Phase I clinical trial application (CTA).
" Nova Mentis (CSE:NOVA) completes production of Psilocybin microdose capsules
Nova Mentis (NOVA) has completed the production of psilocybin microdose capsules in partnership with the Toronto Institute of Pharmaceutical Technology (TIPT).
" Billy Goat (CSE: GOAT) and FunGuys beverage certification
Billy Goat Brands (GOAT) subsidiary FunGuys Beverages has achieved Phase II certification of TerraCycle’s LOOP testing protocols.